BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 15377901)

  • 21. Pushed monocanalicular intubation versus probing for the treatment of simple and incomplete complex types of congenital nasolacrimal duct obstruction in children older than 18 months old.
    Eshraghi B; Khalilipour E; Ameli K; Bazvand F; Mirmohammadsadeghi A
    Orbit; 2017 Aug; 36(4):218-222. PubMed ID: 28627958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of balloon dacryocystoplasty to probing as the primary treatment of congenital nasolacrimal duct obstruction.
    Gunton KB; Chung CW; Schnall BM; Prieto D; Wexler A; Koller HP
    J AAPOS; 2001 Jun; 5(3):139-42. PubMed ID: 11404738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perioperative use of intravenous dexamethasone in the management of congenital nasolacrimal duct obstruction with balloon dacryoplasty.
    Hussein MA; Lopez P
    J AAPOS; 2018 Dec; 22(6):449-451. PubMed ID: 30342184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Balloon catheter dilatation for treatment of congenital nasolacrimal duct obstruction.
    Becker BB; Berry FD; Koller H
    Am J Ophthalmol; 1996 Mar; 121(3):304-9. PubMed ID: 8597274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computed tomographic dacryocystography in children undergoing balloon dacryoplasty.
    Limongi RM; Magacho L; Matayoshi S; Carneiro HM; Avila M
    J AAPOS; 2012 Oct; 16(5):464-7. PubMed ID: 23084386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endoscopic-assisted retrieval of retained lacrimal stent material in congenital nasolacrimal duct obstruction without dacryocystorhinostomy.
    Ng DS; Chan E; Tong FM; Chow SK; Ko ST
    Orbit; 2016; 35(2):103-5. PubMed ID: 26838355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the Masterka for complex nasolacrimal duct obstruction in children.
    Khatib L; Nazemzadeh M; Revere K; Katowitz WR; Katowitz JA
    J AAPOS; 2017 Oct; 21(5):380-383. PubMed ID: 28917994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of treatment for congenital nasolacrimal duct obstruction: a systematic review and meta-analysis.
    Lin AE; Chang YC; Lin MY; Tam KW; Shen YD
    Can J Ophthalmol; 2016 Feb; 51(1):34-40. PubMed ID: 26874157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Balloon dilation of the nasolacrimal duct.
    Tien DR; Young D
    J AAPOS; 2005 Oct; 9(5):465-7. PubMed ID: 16213397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Success Rate of Probing for Congenital Nasolacrimal Duct Obstruction in Children.
    Valcheva KP; Murgova SV; Krivoshiiska EK
    Folia Med (Plovdiv); 2019 Mar; 61(1):97-103. PubMed ID: 31237856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The histopathologic effects of balloon dacryoplasty on the rabbit nasolacrimal duct.
    Goldstein SM; Katowitz JA; Syed NA
    J AAPOS; 2006 Aug; 10(4):333-5. PubMed ID: 16935233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insertion of a preloaded Monoka™ stent for congenital nasolacrimal obstruction: Intraoperative observations. A preliminary study.
    Fayet B; Racy E; Katowitz J; Katowitz W; Ruban JM; Brémond-Gignac D
    J Fr Ophtalmol; 2019 Mar; 42(3):248-254. PubMed ID: 30871792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical Outcomes of Balloon Dacryocystoplasty Combined With Pushed-Type Monocanalicular Intubation as the Primary Management for Congenital Nasolacrimal Duct Obstruction.
    Lai CC; Yang CJ; Lin CC; Chi YC
    J Pediatr Ophthalmol Strabismus; 2021; 58(6):365-369. PubMed ID: 34228567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Balloon dilatation for treatment of congenital nasolacrimal duct obstruction.
    Yüksel D; Ceylan K; Erden O; Kiliç R; Duman S
    Eur J Ophthalmol; 2005; 15(2):179-85. PubMed ID: 15812757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preloaded Monoka (Lacrijet) and congenital nasolacrimal duct obstruction: Initial results.
    Fayet B; Racy E; Ruban JM; Katowitz JA; Katowitz WR; Brémond-Gignac D
    J Fr Ophtalmol; 2021 May; 44(5):670-679. PubMed ID: 33836913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of probing for congenital nasolacrimal duct obstruction in older children.
    Honavar SG; Prakash VE; Rao GN
    Am J Ophthalmol; 2000 Jul; 130(1):42-8. PubMed ID: 11004258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital nasolacrimal duct obstruction update study (CUP study): Paper II - Profile and outcomes of complex CNLDO and masquerades.
    Bansal O; Bothra N; Sharma A; Ali MJ
    Int J Pediatr Otorhinolaryngol; 2020 Dec; 139():110407. PubMed ID: 33068946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Endoscopically Assisted Primary Probing and Bicanalicular Silicone Intubation for Congenital Nasolacrimal Duct Obstruction in Children Aged 4 to 7 Years.
    Arici C; Mergen B; Ozan T; Batu Oto B
    J Pediatr Ophthalmol Strabismus; 2023; 60(2):101-107. PubMed ID: 35446188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Probing with and without Monoka Silastic Stent Intubation for Epiphora in Older Children and Adults.
    Evereklioglu C
    Curr Eye Res; 2020 Jan; 45(1):87-90. PubMed ID: 31403325
    [No Abstract]   [Full Text] [Related]  

  • 40. Probing for congenital nasolacrimal duct obstruction in older children.
    Eshragi B; Fard MA; Masomian B; Akbari M
    Middle East Afr J Ophthalmol; 2013; 20(4):349-52. PubMed ID: 24339688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.